Top 10 Best Vaccine Manufacturers In India 2026

India's vaccine manufacturing sector supplies roughly 60% of the world's vaccine doses, according to industry estimates, and accounts for about 40-70% of all WHO-procured vaccines. That dominance didn't happen by accident. It's the product of decades of capacity building across a handful of companies, from Pune's Serum Institute to Hyderabad's Genome Valley cluster. This ranking of the top 10 best vaccine manufacturers in India for 2026 weighs production scale, WHO prequalification status, indigenous R&D, and public-health reach to identify the companies carrying the sector.

How We Ranked These

Our evaluation drew on 2024-2025 company disclosures, WHO prequalification records, and government immunization program data. We weighed four factors: annual production volume, breadth of WHO-prequalified portfolio, demonstrated R&D capability (particularly indigenous innovation), and contribution to India's Universal Immunization Programme. Scale alone wasn't enough to secure a high position. Companies that combined volume with genuine scientific firsts ranked above pure-volume players, and multinational subsidiaries were assessed separately from domestic manufacturers.

The Top 10 Best Vaccine Manufacturers In India 2026:

1. Serum Institute of India (SII)

No other vaccine company on earth produces more doses than Serum Institute of India. The Pune-based firm, founded in 1966 by Dr. Cyrus Poonawalla, holds an annual capacity of approximately 1.5 billion doses and manufactures between 65% and 70% of all WHO-procured vaccines worldwide.

SII's portfolio covers the backbone of global childhood immunization: DTP, BCG, MMR, and hepatitis B. Its COVID-19 partnerships with AstraZeneca/Oxford (Covishield) and Novavax (Covovax) put Indian manufacturing at the center of the pandemic response. More recently, Cervavac became India's first indigenous HPV vaccine, and the company has malaria and dengue candidates in its pipeline.

The scale is hard to overstate. When SII ramps a production line, it affects vaccine supply on every continent. That reach, combined with WHO prequalification across a broad product range, makes the top spot uncontested.

2. Bharat Biotech International

Bharat Biotech built its reputation on firsts. COVAXIN, developed with the Indian Council of Medical Research, was India's first indigenous COVID-19 vaccine. Typbar-TCV was the world's first WHO-prequalified typhoid conjugate vaccine. Rotavac and JENVAC followed similar paths.

Founded in 1996 by Dr. Krishna Ella and Suchitra Ella, the Hyderabad company operates from Genome Valley with bio-safety level-3 facilities and a cumulative capacity exceeding 500 million doses. Its products reach more than 125 countries. Where SII dominates through volume, Bharat Biotech competes through indigenous R&D, and that distinction matters for India's strategic vaccine independence.

3. Biological E. Limited

Founded in 1953, Biological E. is the oldest company on this list and one of India's largest vaccine producers by volume. Its annual capacity runs to roughly 1 billion doses across products.

BE supplied over 100 million doses of Corbevax, its protein subunit COVID-19 vaccine developed with Baylor College of Medicine in Houston. The company's core business remains DTP-based combination vaccines, hepatitis B, and tetanus toxoid, supplied heavily to public immunization programs. Partnerships for pneumococcal conjugate and dengue vaccines signal where the pipeline is heading. Longevity counts for something in this industry, and BE's seven decades of continuous operation reflect consistent public-health supply.

4. Zydus Lifesciences

Ahmedabad-based Zydus, founded in 1952 by Indravadan Modi, earned its place through a genuine scientific milestone: ZyCoV-D, the world's first DNA-based COVID-19 vaccine to receive emergency use approval anywhere, cleared by Indian regulators in 2021.

The company reported annual revenue above ₹19,000 crore in FY2024, making it one of the largest pharmaceutical firms on this list by turnover. Its vaccine operations run through the Zydus Vaxxicare arm, backed by a substantial R&D pipeline. Zydus isn't primarily a vaccine company the way SII or Bharat Biotech are, but the plasmid DNA platform gives it a technological edge few competitors can match.

5. Indian Immunologicals Limited (IIL)

Indian Immunologicals occupies a dual role that no other company here replicates: it's the largest supplier of animal vaccines in India and a major human vaccine manufacturer producing around 150 million doses annually.

Founded in 1982 and owned by the National Dairy Development Board, IIL supplies rabies, DTP, tetanus, and hepatitis B vaccines for human use while maintaining a vast veterinary portfolio. The public-sector backing gives it a reliability profile that private firms can't always guarantee during supply crunches. Its expansion into newer vaccine platforms is worth watching through 2026.

6. Panacea Biotec

Delhi-based Panacea Biotec, established in 1984, built its business on combination vaccines. Easyfive, its pentavalent vaccine, is among the company's flagship products, and the firm ranks as one of India's largest suppliers of DTP-based combinations.

WHO prequalification underpins its export credentials, with a presence in more than 50 countries. Panacea has supplied oral polio and DTP vaccines to UN agencies, and it partnered with global firms on Sputnik V production during the pandemic. The company's strength lies in steady institutional supply rather than headline-grabbing innovation, and that reliability has kept it relevant for four decades.

7. Haffkine Bio-Pharmaceutical Corporation

Haffkine is the oldest institution on this list, established in Mumbai in 1899 and named after Dr. Waldemar Haffkine, the bacteriologist who developed an early plague vaccine. It operates as a Government of Maharashtra undertaking.

Current production covers DPT group vaccines, anti-rabies serum, and snake antivenom. Haffkine was also involved in COVID-19 vaccine development efforts during the pandemic. Its manufacturing capacity doesn't rival the private giants, but its role in public-health emergencies and government-backed supply gives it standing that pure market metrics would miss.

8. Bio-Med (P) Limited

Based in Ghaziabad, Uttar Pradesh, Bio-Med is a privately held manufacturer focused squarely on diphtheria, tetanus, and pertussis-based vaccines along with other biologicals for India's Universal Immunization Programme.

The company doesn't chase global export markets the way larger peers do. Its contribution is narrower but consistent: keeping DPT, DT, and TT vaccine lines supplied to national programs. For a country immunizing roughly 26 million infants annually, that steady domestic supply matters as much as billion-dose export capacity.

9. Mynvax

Mynvax is the outlier here: a startup spun out of the Indian Institute of Science, Bengaluru, with no billion-dose factory floor. What it has is a thermotolerant vaccine platform aimed at eliminating cold-chain dependence, a problem that limits immunization reach across rural India and much of the developing world.

Its heat-stable COVID-19 candidate drew international attention for remaining stable without refrigeration. Backed by national research grants, Mynvax represents the R&D pipeline that will determine whether India's vaccine leadership survives the next decade. Small scale, significant potential.

10. Sanofi India and GSK Pharmaceuticals India

The multinational presence in Indian vaccine manufacturing runs through two global leaders. Sanofi operates a major manufacturing site at Ankleshwar, Gujarat, producing and supplying vaccines for the Indian market. GSK Pharmaceuticals India distributes hepatitis, influenza, and DTP combination vaccines domestically.

Both companies bring global R&D resources and quality standards into India's supply chain, though their Indian operations function more as manufacturing and distribution arms than standalone vaccine developers. They rank tenth because their contribution to domestic supply is real but narrower than the indigenous manufacturers above them. For readers tracking multinational pharmaceutical operations in India, our coverage of pharmaceutical manufacturing hubs offers related context.